{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-000622","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2022-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.300264+00:00","generated_at":"2026-06-27T19:18:05.068533+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Puma Biotechnology CEO to present at investor conferences beginning Jan 10, 2022","bullets":["CEO Alan Auerbach will present at conferences and other forums starting January 10, 2022.","Presentation slides attached as Exhibit 99.1 contain the information to be disclosed.","No specific financial or operational details from the slides are available in this filing text."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-000622","json":"https://secwatch.observer/filing/0001437749-22-000622.json","markdown":"https://secwatch.observer/filing/0001437749-22-000622.md","text":"https://secwatch.observer/filing/0001437749-22-000622.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922000622/0001437749-22-000622-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922000622/pbyi20220106_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T19:18:05.068533+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}